Results per Page:
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger”
Dr. Sara Hurvitz receives the Smith Family Endowed Chair in Women’s Health
Flexible funding will fuel physician-scientist’s work to improve survivorship for women with cancer
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
Surprising findings about blood cell mutations bode well for transplant recipients
Fred Hutch researchers compared blood samples from 16 recipient-donor pairs, some more than 45 years after transplant
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Fred Hutch Phase 1 Program director, Dr. John Thompson, retires
An immunotherapy champion, Thompson co-led the melanoma clinic for decades
A charming model: new tool evaluates risk of transplant for older patients
Seven values are evaluated to predict outcomes
Barriers to adherence of 1-year surveillance colonoscopy for CRC patients
From the Issaka Lab, Public Health Sciences and Clinical Research Divisions
Successful long-term outcomes for unrelated bone marrow transplants
From the Deeg Lab, Clinical Research Division
New funding drives six breast cancer studies
Scientists from Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium receive $1.7M in grants from Breast Cancer Research Foundation
Mapping tumor cell heterogeneity in castrate-resistant prostate cancer
From the Haffner Lab, Human Biology and Clinical Research Divisions
Graft-versus-host disease outcomes improving for all Fred Hutch patients
From the Long-Term Follow-Up Research Group, Clinical Research Division
Let’s give these CAR(T cell)s some pedals!
From Dr. Jacob Appelbaum, Fred Hutch Clinical Research Division and Seattle Children’s Therapeutics, Seattle Children’s Hospital
Age or HLA? Helping doctors pick the best blood stem cell donors for their patients
From Drs. Rohtesh Mehta and Stephanie Lee, Clinical Research Division
Dr. Mazyar Shadman, new medical director of the Bezos Family Immunotherapy Clinic, says immunotherapy services are expanding to meet demand
Increasing timely access to immunotherapy is a main goal